by Jan A.C. Hontelez, Angela Y. Chang, Osondu Ogbuoji et al.
AIDS: 24 September 2016, Vol. 30, Issue 15, pp. 2341–2350
The authors estimated the investment needs, population health gains, and cost-effectiveness of different policy options for scaling-up prevention and treatment of HIV in the 10 countries that currently comprise 80% of all people living with HIV in sub-Saharan Africa (Ethiopia, Kenya, Malawi, Mozambique, Nigeria, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe). They conclude that treatment eligibility at any CD4+ cell count would be cost-effective, even under health system constraints.